# Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)

> **NCT01136694** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 695 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01136694
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-12
- **Target enrollment:** 695 (ACTUAL)
- **Last updated:** 2012-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136694, "Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01136694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*